MedPath

Hemodynamic-GUIDEd Management of Heart Failure

Not Applicable
Completed
Conditions
Heart Failure, Systolic
Heart Failure NYHA Class II
Heart Failure
Heart Failure, Diastolic
Heart Failure NYHA Class III
Heart Failure With Reduced Ejection Fraction
Heart Failure,Congestive
Heart Failure; With Decompensation
Heart Failure NYHA Class IV
Heart Failure With Normal Ejection Fraction
Interventions
Device: CardioMEMS™ HF System
Registration Number
NCT03387813
Lead Sponsor
Abbott Medical Devices
Brief Summary

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population including heart failure (HF) patients outside of the present indication, but at risk for future HF events or mortality.

Detailed Description

The GUIDE-HF IDE clinical trial is intended to demonstrate the effectiveness of the CardioMEMS™ HF System in an expanded patient population including HF patients outside of the present indication, but at risk for future HF events or mortality.

The trial includes patients with New York Heart Association (NYHA) Class II, III, or IV HF who have an elevated N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) (or an elevated Brain Natriuretic Peptide (BNP)) and/or a prior HF hospitalization (HFH).

The GUIDE-HF IDE trial will include approximately 3600 subjects at approximately 140 North American sites and consists of two arms: a Randomized Arm and a Single Arm.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2358
Inclusion Criteria
  1. Diagnosis and treatment for heart failure (HF) (regardless of left ventricular ejection fraction (LVEF)) for > 90 days prior to the date of consent:

    a. Subjects should be on stable, optimally titrated medical therapy for at least 30 days, as recommended according to current American Heart Association (AHA)/American College of Cardiology (ACC) guidelines as standard-of-care for HF therapy in the United States, with any intolerance documented.

  2. GUIDE-HF Randomized Arm Only: NYHA Class II, III or IV HF symptoms documented within 30 days prior to consent.

  3. GUIDE-HF Single Arm Only: NYHA Class III HF symptoms documented within 30 days prior to consent.

  4. HF hospitalization (HFH) within 12 months prior to consent and/or elevated N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) (or Brain Natriuretic Peptide (BNP)) within 30 days prior to consent defined as:

    1. Subjects with LVEF ≤ 40%: NT-proBNP ≥ 1000 pg/mL (or BNP ≥ 250 pg/mL).
    2. Subjects with LVEF > 40%: NT-proBNP ≥ 700 pg/mL (or BNP ≥ 175 pg/mL).
    3. Thresholds for NT-proBNP and BNP (for both LVEF ≤ 40% and LVEF > 40%) will be corrected for body mass index (BMI) using a 4% reduction per BMI unit over 25 kg/m2
  5. ≥ 18 years of age

  6. Chest circumference of < 65 inches, if BMI is > 35 kg/m2

  7. Written informed consent obtained from subject

  8. Willing and able to upload pulmonary artery (PA) pressure information and comply with the follow-up requirements

Exclusion Criteria
  1. Intolerance to all neuro-hormonal antagonists (i.e., intolerance to angiotensin converting enzyme-inhibitors (ACE-I), angiotensin receptor blockers (ARB), angiotensin-neprilysin inhibitors (ARNi), hydralazine/isosorbide dinitrate and beta-blockers)

  2. ACC/AHA Stage D refractory HF (including having received or currently receiving pharmacologic circulatory support with inotropes)

  3. Received or are likely to receive an advanced therapy (e.g., mechanical circulatory support or cardiac transplant) in the next 12 months

  4. NYHA Class IV HF patients with:

    1. Continuous or chronic use of scheduled intermittent inotropic therapy for HF and an INTERMACS level of ≤ 4, OR
    2. Persistence of fluid overload with maximum (or dose equivalent) diuretic intervention
  5. Glomerular Filtration Rate (eGFR) < 25 mL/min and non-responsive to diuretic therapy, or receiving chronic dialysis

  6. Inability to tolerate or receive dual antiplatelet therapy or anticoagulation therapy for one month post-implantation

  7. Significant congenital heart disease that has not been repaired and would prevent implantation of the CardioMEMS™ PA Sensor

  8. Implanted with mechanical right heart valve(s)

  9. Unrepaired severe valvular disease

  10. Pregnant or planning to become pregnant in the next 12 months

  11. An active, ongoing infection, defined as being febrile, an elevated white blood cell count, on intravenous antibiotics, and/or positive cultures (blood, sputum or urine).

  12. History of current or recurrent (≥ 2 episodes within 5 years prior to consent) pulmonary emboli and/or deep vein thrombosis

  13. Major cardiovascular event (e.g., unstable angina, myocardial infarction, percutaneous coronary intervention, open heart surgery, or stroke, etc.) within 90 days prior to consent

  14. Implanted with Cardiac Resynchronization Therapy (CRT)-Pacemaker (CRT-P) or CRT-Defibrillator (CRT-D) for less than 90 days prior to consent

  15. Enrollment into another trial with an active treatment arm

  16. Anticipated life expectancy of < 12 months

  17. Any condition that, in the opinion of the Investigator, would not allow for utilization of the CardioMEMS™ HF System to manage the subject using information gained from hemodynamic measurements to adjust medications, including the presence of unexpectedly severe pulmonary hypertension (e.g., trans-pulmonary gradient >15) at implant right heart catheterization (RHC), a history of non-compliance, or any condition that would preclude CardioMEMS™ PA Sensor implantation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single ArmCardioMEMS™ HF SystemManagement of subjects based on PA pressure information derived from the CardioMEMS™ HF System. All subjects will receive a CardioMEMS™ HF System.
Randomized Arm - Treatment GroupCardioMEMS™ HF SystemManagement of subjects based on pulmonary artery (PA) pressure information derived from the CardioMEMS™ HF System. All subjects will receive a CardioMEMS™ HF System.
Randomized Arm - Control GroupCardioMEMS™ HF SystemManagement of subjects per standard of care (signs, symptoms, weight etc.) without knowledge of PA pressure information derived from the CardioMEMS™ HF System. All subjects will receive a CardioMEMS™ HF System.
Primary Outcome Measures
NameTimeMethod
(Randomized Arm) Composite outcome of (1) HFHs, (2) intravenous diuretic visits, and (3) all-cause mortality12 months post-implantation

The composite of:

1. The number of recurrent HFHs

2. The number of emergency department/hospital outpatient observation visits for intravenous diuretic therapy

3. The number of deaths of any cause

added together with equal weighting into a total number of events

(Single Arm) Composite outcome of (1) HFHs, (2) intravenous diuretic visits, and (3) all-cause mortality12 months post-implantation

The composite outcome of:

1. The number of recurrent HFHs

2. The number of emergency department/hospital outpatient observation visits for intravenous diuretic therapy

3. The number of deaths of any cause

added together with equal weighting into a total number of events

Secondary Outcome Measures
NameTimeMethod
(Single Arm) HFHs post- vs. pre-implantation12 months post-implantation

The number of HFHs at 12 months post-implantation compared to the number of HFHs in the 12 months prior to implantation

(Randomized Arm) Composite outcome of (1) HFHs and (2) intravenous diuretic visits12 months post-implantation

The composite outcome of:

1. The number of recurrent HFHs

2. The number of emergency department/hospital outpatient observation visits for intravenous diuretic therapy

added together with equal weighting into a total number of events

(Randomized Arm) EQ-5D-5LBaseline, 6, and 12 months post-implantation

Health status as assessed by the EuroQol 5-Dimension, 5-Level (EQ-5D-5L) Questionnaire

(Randomized Arm) 6MHW TestBaseline, 6, and 12 months post-implantation

Six Minute Hall Walk (6MHW) Test Distance

(Randomized Arm) Intravenous diuretic visits12 months post-implantation

The number of emergency department/hospital outpatient observation visits for intravenous diuretic therapy

(Randomized Arm) All-cause mortality12 months post-implantation

The number of deaths of any cause

(Single Arm) Intravenous diuretic visits12 months post-implantation

The number of emergency department/hospital outpatient observation visits for intravenous diuretic therapy

(Single Arm) All-cause mortality12 months post-implantation

The number of deaths of any cause

(Single Arm) Safety: Freedom from DSRCs12 months post-implantation

Freedom from DSRCs

(Randomized Arm) HFHs12 months post-implantation

The number of recurrent HFHs

(Single Arm) Composite outcome of (1) HFHs and (2) intravenous diuretic visits12 months post-implantation

The composite outcome of:

1. The number of recurrent HFHs

2. The number of emergency department/hospital outpatient observation visits for intravenous diuretic therapy

added together with equal weighting into a total number of events

(Randomized Arm) KCCQ-12Baseline, 6, and 12 months post-implantation

Health status as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ-12)

(Randomized Arm) Safety: Freedom from DSRCs12 months post-implantation

Freedom from device/system related complications (DSRCs)

(Single Arm) HFHs12 months post-implantation

The number of HFHs

Trial Locations

Locations (134)

Baylor University Hospital

🇺🇸

Dallas, Texas, United States

Ohio State University

🇺🇸

Columbus, Ohio, United States

Hospital of the University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

Ronald Reagan UCLA Medical Center

🇺🇸

Los Angeles, California, United States

The Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

John Muir Medical Center

🇺🇸

Concord, California, United States

Memorial Hermann Hospital

🇺🇸

Houston, Texas, United States

The Methodist Hospital

🇺🇸

Houston, Texas, United States

University of Washington Medical Center

🇺🇸

Seattle, Washington, United States

Providence Hospital

🇺🇸

Southfield, Michigan, United States

Iowa Heart Center

🇺🇸

West Des Moines, Iowa, United States

John Peter Smith Hospital

🇺🇸

Fort Worth, Texas, United States

St. Francis Hospital

🇺🇸

Roslyn, New York, United States

Akron City Hospital

🇺🇸

Akron, Ohio, United States

San Diego Cardiac Center

🇺🇸

San Diego, California, United States

Mercy Hospital

🇺🇸

Miami, Florida, United States

St. Vincent Hospital

🇺🇸

Indianapolis, Indiana, United States

Minneapolis Heart Institute

🇺🇸

Minneapolis, Minnesota, United States

Kansas University Medical Center

🇺🇸

Kansas City, Kansas, United States

Prisma Health-Midlands

🇺🇸

Columbia, South Carolina, United States

Advocate Health and Hospitals Corporation

🇺🇸

Oakbrook Terrace, Illinois, United States

University Hospitals Cleveland Medical Center

🇺🇸

Cleveland, Ohio, United States

Lancaster General Hospital

🇺🇸

Lancaster, Pennsylvania, United States

University of Arizona

🇺🇸

Tucson, Arizona, United States

Abington Memorial Hospital

🇺🇸

Abington, Pennsylvania, United States

Saint Barnabas Medical Center

🇺🇸

Livingston, New Jersey, United States

North Colorado Medical Center

🇺🇸

Greeley, Colorado, United States

Methodist Healthcare System of San Antonio

🇺🇸

San Antonio, Texas, United States

Sentara Norfolk General Hospital

🇺🇸

Norfolk, Virginia, United States

Waukesha Memorial Hospital

🇺🇸

Waukesha, Wisconsin, United States

Vancouver General Hospital (U of BC)

🇨🇦

Vancouver, British Columbia, Canada

Swedish Medical Center - Heart & Vascular

🇺🇸

Seattle, Washington, United States

Virginia Heart - The Cardiovascular Group, P.C.

🇺🇸

Falls Church, Virginia, United States

Winchester Medical Center

🇺🇸

Winchester, Virginia, United States

Providence Everett Medical Center

🇺🇸

Everett, Washington, United States

Foothills Medical Centre

🇨🇦

Calgary, Alberta, Canada

Southlake Regional Health Centre

🇨🇦

Newmarket, Ontario, Canada

Toronto General Hospital

🇨🇦

Toronto, Ontario, Canada

Banner-University Medical Center Phoenix

🇺🇸

Phoenix, Arizona, United States

Phoenix Cardiovascular Research Group

🇺🇸

Phoenix, Arizona, United States

California Pacific Medical Center - Van Ness Campus

🇺🇸

San Francisco, California, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

University of Nebraska Medical Center

🇺🇸

Omaha, Nebraska, United States

Integris Baptist Medical Center

🇺🇸

Oklahoma City, Oklahoma, United States

Oklahoma Heart Hospital South

🇺🇸

Oklahoma City, Oklahoma, United States

Providence Heart and Vascular

🇺🇸

Portland, Oregon, United States

Aurora Medical Group

🇺🇸

Milwaukee, Wisconsin, United States

University of Colorado Hospital

🇺🇸

Aurora, Colorado, United States

Arizona Cardiovascular Research Center

🇺🇸

Phoenix, Arizona, United States

Baptist Health Medical Center

🇺🇸

Little Rock, Arkansas, United States

Washington Regional Medical Center

🇺🇸

Fayetteville, Arkansas, United States

Arkansas Heart Hospital

🇺🇸

Little Rock, Arkansas, United States

USC University Hospital

🇺🇸

Los Angeles, California, United States

University of California at San Diego (UCSD) Medical Center

🇺🇸

La Jolla, California, United States

Scripps Health

🇺🇸

La Jolla, California, United States

Adventist Health St. Helena

🇺🇸

Deer Park, California, United States

Ventura Cardiology Consultants

🇺🇸

Ventura, California, United States

South Denver Cardiology Associates PC

🇺🇸

Littleton, Colorado, United States

George Washington University Hospital

🇺🇸

Washington, District of Columbia, United States

Bethesda Memorial Hospital

🇺🇸

Boynton Beach, Florida, United States

Morton Plant Hospital

🇺🇸

Clearwater, Florida, United States

Memorial Regional Hospital

🇺🇸

Hollywood, Florida, United States

Tampa General Hospital

🇺🇸

Tampa, Florida, United States

First Coast Cardiovascular Institute

🇺🇸

Jacksonville, Florida, United States

Memorial Hospital Jacksonville

🇺🇸

Jacksonville, Florida, United States

Piedmont Athens Regional Medical Center

🇺🇸

Athens, Georgia, United States

University Hospital

🇺🇸

Augusta, Georgia, United States

Northshore University HealthSystem

🇺🇸

Evanston, Illinois, United States

Midwest Cardiovascular Institute

🇺🇸

Naperville, Illinois, United States

Cardiovascular Research Institute of Kansas

🇺🇸

Wichita, Kansas, United States

Cardiovascular Institute of the South

🇺🇸

Houma, Louisiana, United States

Advanced Cardiovascular Specialists

🇺🇸

Shreveport, Louisiana, United States

Brigham and Women's Hospital

🇺🇸

Boston, Massachusetts, United States

University of Massachusetts

🇺🇸

Worcester, Massachusetts, United States

MidMichigan Medical Center-Midland

🇺🇸

Midland, Michigan, United States

McLaren Health Care Corporation

🇺🇸

Auburn Hills, Michigan, United States

Mayo Clinic

🇺🇸

Rochester, Minnesota, United States

University of Minnesota Medical Center Fairview

🇺🇸

Minneapolis, Minnesota, United States

North Kansas City Hospital

🇺🇸

North Kansas City, Missouri, United States

St. Cloud Hospital

🇺🇸

Saint Cloud, Minnesota, United States

Mercy Hospital St. Louis

🇺🇸

Saint Louis, Missouri, United States

BryanLGH Heart Institute

🇺🇸

Lincoln, Nebraska, United States

Renown Regional Medical Center

🇺🇸

Reno, Nevada, United States

Catholic Medical Center

🇺🇸

Manchester, New Hampshire, United States

Lourdes Cardiology Services

🇺🇸

Voorhees, New Jersey, United States

New York University Hospital

🇺🇸

New York, New York, United States

Mount Sinai Hospital

🇺🇸

New York, New York, United States

New York-Presbyterian/Columbia University

🇺🇸

New York, New York, United States

Hudson Valley Cardiovascular Practice, P.C.

🇺🇸

Poughkeepsie, New York, United States

Rochester General Hospital

🇺🇸

Rochester, New York, United States

Vidant Medical Center

🇺🇸

Greenville, North Carolina, United States

WakeMed Hospital

🇺🇸

Raleigh, North Carolina, United States

Carolinas Medical Center

🇺🇸

Charlotte, North Carolina, United States

Ohio Health Research Institute

🇺🇸

Columbus, Ohio, United States

St. Elizabeth Health Center

🇺🇸

Youngstown, Ohio, United States

Tennova Healthcare - Turkey Creek Medical Center

🇺🇸

Knoxville, Tennessee, United States

Pinnacle Health System

🇺🇸

Harrisburg, Pennsylvania, United States

Albert Einstein Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

The Reading Hospital and Medical Center

🇺🇸

West Reading, Pennsylvania, United States

Main Line Health Center/Lankenau Hospital

🇺🇸

Wynnewood, Pennsylvania, United States

Methodist University Hospital

🇺🇸

Memphis, Tennessee, United States

Allegheny General Hospital - ASRI

🇺🇸

Pittsburgh, Pennsylvania, United States

Greenville Health System

🇺🇸

Greenville, South Carolina, United States

Sanford USD Medical Center

🇺🇸

Sioux Falls, South Dakota, United States

St Thomas Hospital

🇺🇸

Nashville, Tennessee, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

CHI St. Luke's Health Baylor College of Medicine Med. Ctr.

🇺🇸

Houston, Texas, United States

Park Plaza Hospital

🇺🇸

Houston, Texas, United States

Sparrow Clinical Research Institute

🇺🇸

Lansing, Michigan, United States

Eisenhower Medical Center

🇺🇸

Rancho Mirage, California, United States

WellStar Kennestone Hospital

🇺🇸

Marietta, Georgia, United States

Heart Center of Lake County

🇺🇸

Merrillville, Indiana, United States

Aspirus Wausau Hospital

🇺🇸

Wausau, Wisconsin, United States

Hartford Hospital

🇺🇸

Hartford, Connecticut, United States

Our Lady of the Lake Hospital

🇺🇸

Baton Rouge, Louisiana, United States

Deborah Heart and Lung Center

🇺🇸

Browns Mills, New Jersey, United States

Hackensack University Medical Center

🇺🇸

Hackensack, New Jersey, United States

NC Heart and Vascular Research

🇺🇸

Raleigh, North Carolina, United States

Oklahoma Heart Institute at Utica

🇺🇸

Tulsa, Oklahoma, United States

Penn State Milton S. Hershey Medical Center

🇺🇸

Hershey, Pennsylvania, United States

Sutter Medical Center, Sacramento

🇺🇸

Sacramento, California, United States

Mercy Medical Group - Cardiology

🇺🇸

Sacramento, California, United States

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

St. Luke's Hospital

🇺🇸

Kansas City, Missouri, United States

Yale New Haven Hospital

🇺🇸

New Haven, Connecticut, United States

Advent Health Orlando

🇺🇸

Orlando, Florida, United States

Orlando Regional Medical Center

🇺🇸

Orlando, Florida, United States

Louisiana State University Health Sciences Center

🇺🇸

New Orleans, Louisiana, United States

Ochsner Medical Center

🇺🇸

New Orleans, Louisiana, United States

Acension Texas Cardiovascular

🇺🇸

Austin, Texas, United States

Austin Heart

🇺🇸

Austin, Texas, United States

Bon Secours Heart & Vascular Institute

🇺🇸

Richmond, Virginia, United States

New Mexico Heart Institute

🇺🇸

Albuquerque, New Mexico, United States

Rhode Island Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath